View in EDS HTML Full Text PDF Full Text

Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps.

Saved in:
Bibliographic Details
Title: Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps.
Authors: Jacobs JS; Allergy and Asthma Clinical Research, 370 North Widget Lane, Suite 210, Walnut Creek, CA, 94598, USA. jjacobs@bayareaallergy.com., Han JK; Department of Otolaryngology & Head & Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA., Lee JK; Evidence Based Medical Educator Inc., Toronto, ON, Canada.; Toronto Allergy and Asthma Clinic, Toronto, ON, Canada., Laidlaw TM; Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Martin NL; Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.; Cytel Inc., Waltham, MA, USA.; Global Development, Inflammation, R&D, Amgen, Thousand Oaks, CA, USA., Caveney S; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Martin N; Institute for Lung Health, National Institute for Health and Care Research, Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Spahn JD; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA., Hoyte FCL; Division of Allergy and Immunology, National Jewish Health, Denver, CO, USA.
Source: Advances in therapy [Adv Ther] 2025 Jan; Vol. 42 (1), pp. 510-522. Date of Electronic Publication: 2024 Nov 08.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39514041
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jacobs+JS%22">Jacobs JS</searchLink>; Allergy and Asthma Clinical Research, 370 North Widget Lane, Suite 210, Walnut Creek, CA, 94598, USA. jjacobs@bayareaallergy.com.<br /><searchLink fieldCode="AU" term="%22Han+JK%22">Han JK</searchLink>; Department of Otolaryngology & Head & Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+JK%22">Lee JK</searchLink>; Evidence Based Medical Educator Inc., Toronto, ON, Canada.; Toronto Allergy and Asthma Clinic, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Laidlaw+TM%22">Laidlaw TM</searchLink>; Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Martin+NL%22">Martin NL</searchLink>; Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.; Cytel Inc., Waltham, MA, USA.; Global Development, Inflammation, R&D, Amgen, Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Caveney+S%22">Caveney S</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ambrose+CS%22">Ambrose CS</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Martin+N%22">Martin N</searchLink>; Institute for Lung Health, National Institute for Health and Care Research, Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Spahn+JD%22">Spahn JD</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Hoyte+FCL%22">Hoyte FCL</searchLink>; Division of Allergy and Immunology, National Jewish Health, Denver, CO, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Jan; Vol. 42 (1), pp. 510-522. <i>Date of Electronic Publication: </i>2024 Nov 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39514041
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-024-03006-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 510
    Titles:
      – TitleFull: Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jacobs JS
      – PersonEntity:
          Name:
            NameFull: Han JK
      – PersonEntity:
          Name:
            NameFull: Lee JK
      – PersonEntity:
          Name:
            NameFull: Laidlaw TM
      – PersonEntity:
          Name:
            NameFull: Martin NL
      – PersonEntity:
          Name:
            NameFull: Caveney S
      – PersonEntity:
          Name:
            NameFull: Ambrose CS
      – PersonEntity:
          Name:
            NameFull: Martin N
      – PersonEntity:
          Name:
            NameFull: Spahn JD
      – PersonEntity:
          Name:
            NameFull: Hoyte FCL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1